Beneficial Effects of Oral Carbon Monoxide on Doxorubicin‐Induced Cardiotoxicity

Rodrigo Wagner Alves de Souza(Beth Israel Deaconess Medical Center), Leo E. Otterbein(Beth Israel Deaconess Medical Center), Mark S. Young(Hillhurst Biopharmaceuticals (United States)), Edward D. Gomperts(Children's Hospital of Los Angeles), Andrew Gomperts(Hillhurst Biopharmaceuticals (United States)), Vanessa Azevedo Voltarelli(Beth Israel Deaconess Medical Center), David Gallo(Beth Israel Deaconess Medical Center), Michael S. Tift(University of North Carolina Wilmington)
Journal of the American Heart Association
May 3, 2024
Cited by 6


Related Papers